Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 20 $ 576
Restricted cash 112 374
Deferred course expenses 266 304
Prepaid expenses and other current assets 347 607
Inventory 1 1
Discontinued operations current assets
Total current assets 746 1,862
Right-of-use assets 6 20
Other assets 6 6
Discontinued operations-other assets 32 33
Total assets 790 1,921
Current liabilities:    
Accounts payable 2,607 2,544
Royalties payable 110 110
Accrued course expenses 238 252
Accrued salaries, wages and benefits 237 202
Operating lease liability, current portion 7 20
Other accrued expenses 616 2,114
Deferred revenue 4,173 4,438
Short-term related party debt, net of unamortized debt discount of $133 392 142
Current portion of long term debt, net of unamortized debt discount of $0 344 1,011
Discontinued operations-current liabilities 10,802 9,845
Total current liabilities 19,526 20,678
Long-term debt, net of current portion and net of unamortized debt discount 2,840 1,933
Deferred tax liability, net 1,336 1,493
Other long term liabilities
Operating lease liability, net of current portion
Total liabilities 23,702 24,104
Commitments and contingencies (Note 13)  
Stockholders’ deficit:    
Preferred stock, $0.0001 par value, 20,000,000 shares authorized, none issued
Common stock, $0.0001 par value; 200,000,000 authorized; 34,167,697 and 33,917,697 shares issued and outstanding as of June 30, 2022 and December 31, 2021 3 3
Additional paid-in capital 13,211 13,161
Cumulative foreign currency translation adjustment 1,458 837
Accumulated deficit (37,584) (36,184)
Total stockholders’ deficit (22,912) (22,183)
Total liabilities and stockholders’ deficit $ 790 $ 1,921